Clinical Trials Browser

Phase 2 × OTHER_GOV × HR+/HER2- Breast Cancer × Clear all

NCT06860529 2025-06-23

Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Phase 2 Recruiting

HR+/HER2- Breast Cancer